Sophiris Bio's IPO - II Round

Sophiris Bio raised a round of funding on August 16, 2013. Investors include Public.

Sophiris Bio (SHS.TO) is a Canadian urology company with operations based in San Diego developing a late-stage, highly targeted treatment for benign prostatic hyperplasia (BPH or enlarged prostate), a…

Articles about Sophiris Bio's IPO - II Round: